At Latus Bio, we are developing novel therapeutics for CNS disorders with our revolutionary AAV capsids. We have developed capsid variants with unprecedented potency, specificity, and trophism. All of our capsids were designed with a particular disease in mind, in order to find the right capsid and the right route of administration to target the most relevant brain regions and cell types for each specific indication. Founded on the groundbreaking work of Professor Beverly Davidson from the Children's Hospital of Philadelphia, Latus Bio is committed to transforming patient care through targeted, potent, and safe gene therapies. We are focused on CNS diseases such as CLN2 (Batten Disease) and Huntington’s Disease, aiming to fundamentally alter the course of these challenging conditions by always putting the patients first. We are not just developing therapies; we are revolutionizing the future of healthcare with innovations that reduce therapeutic load, enhance safety, facilitate manufacturing, and expand access. Latus Bio is powered by a diverse team of visionary scientists, clinicians, and industry leaders dedicated to tackling some of the most complex neurological disorders. With a robust pipeline and a strategy to enter clinical trials by late 2025, we are poised to make significant strides quickly. Be part of this transformative movement at Latus Bio. Let's unlock the potential of gene therapy to bring hope and healing to millions around the globe. Learn more about our mission, our people, and our promise at www.latusbio.com and connect with us on LinkedIn to follow our progress.
External link for Latus Bio
Latus Bio reposted this
What a spectacular event last night celebrating the HD community at The Franklin Institute in Philadelphia. Our guest speakers Beverly Davidson, Leslie Thompson and Jang-Ho Cha, 2023 recipients of HDF's $1M Transformative Research Awards, highlighted the incredible strides in science toward treatments for Huntington's Disease. Thank you to everyone who attended. It was a night to remember! #huntingtonsdisease #findacure #cureHD
Photos from #BiotechAlchemy capture the Panel at the Life Sciences Summit in Philadelphia where Latus Bio was recognized as one of the “Groundbreakers -Five Companies Changing the Paradigm” #bbstudio
Next week, Jang-Ho Cha will be discussing Financing Successes and Leading Investment Opportunities at the #phillybuildsbio Annual Symposium for Life Science Innovation & Development. See the full agenda here https://lnkd.in/gf5pf5VM #latusbio #funding
We are pleased to share that Latus Bio, Inc. has recognized by #BiotechAlchemy as one of the “Groundbreakers -Five Companies Changing the Paradigm” P. Peter Ghoroghchian, M.D., Ph.D. will be participating in the Emerging Companies Panel at next week’s Life Sciences Summit in Philadelphia https://lnkd.in/e9Ji3U7t
We're just two weeks away from our highly anticipated #BiotechAlchemy Conference in #Philadelphia. This event will bring together innovators, investors, patient advocacy groups, and other important stakeholders across the life sciences industry. The day will feature exciting discussions on topics, including: 💲 Biotech Capital Markets 💡 Generative AI in the Life Sciences 👥 Workforce Development for Growing Companies 💉 The Role of Patient Advocacy in Drug Development & Approval 📈 VC Investment Strategies 🏙 Emerging Companies in Philadelphia The day will wrap up with a networking cocktail reception, a great opportunity to connect with peers and industry experts. We're so very excited to see you all there! Please visit www.biotechalchemy.com to purchase tickets, accommodation, and view the full agenda. #BiotechAlchemy #LifeSciences #PhiladelphiaBiotech #Conference
At Latus Bio, we are developing CNS gene therapy candidates, using proprietary technologies that have been used to identify and engineer novel adeno-associated virus (AAV) capsid variants with the aim of showing unprecedented potency, specificity, and safety. We are honored to attend this year's American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore, MD, May 7 – 11, 2024. Latus will be hosting a Speaker Showcase on May 7th from 5pm to 6:30 pm at the Baltimore Convention Center in Room 343 to explore the challenges, opportunities and goals for gene therapy programs in CNS. We are joined by our illustrious guest speakers: Beverly Davidson, Children’s Hospital of Philadelphia and Latus SAB Chair Sarah Tabrizi, University College of London Rebecca Ahrens-Nicklas, Children’s Hospital of Philadelphia Angela Schulz, University Medical Center Hamburg-Eppendorf Further, Latus co-founder Professor Beverly Davidson will be a conference keynote speaker on May 9th. Her address will highlight the Company's progress and the vast potential of its technology to solve unmet needs in CNS gene therapy. We look forward to seeing everyone there. https://lnkd.in/ecDxYCcD
At #ASGCT2024, Beverly Davidson, PhD, Children's Hospital of Philadelphia Research Institute Chief Scientific Strategy Officer, will present as the Keynote Speaker for the George Stamatoyannopoulos Memorial Lecture in Baltimore, Maryland! An expert in cell and gene therapy research and leader of the Clinical Vector Core (CVC) at Children's Hospital of Philadelphia, Dr. Davidson will speak on "Unlocking the Power of AAVs for Brain Gene Therapies" on May 9. Interested in learning more about the CVC's history of developing and manufacturing viral vectors? Head over to our website: http://ms.spr.ly/6044YpPMu #GeneticDisease #GeneEditing #CellTherapy #GeneTherapy #Vector #ClinicalResearch #ASGCT24
Allow us to introduce ourselves—we are Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), using proprietary technologies to identify and engineer novel adeno-associated virus (AAV) capsid variants with the aim of showing unprecedented potency, specificity, and safety. Today, we’re thrilled to publicly launch with an initial $54 million in Series A financing, led by 8VC and DCVC Bio. Thanks to Kyle LaHucik at Endpoints for capturing our story! 👇 https://lnkd.in/gZURHqnN We look forward to sharing our journey with you. For more information on Latus, visit our website: www.latusbio.com